SHIELD T3, LLC founded in 2020 is solely owned by the Board of Trustees of the University of Illinois and functions as a university-related organization. SHIELD T3’s primary mission is to expand the reach of saliva-based COVID-19 testing pioneered by the University of Illinois researchers.
Leadership Team
Laura Wand
Chief Executive Officer (Interim)
Bob Ludtke
Chief Operations Officer
Michael Beck
Chief Financial Officer
David Clark
Chief Commercial Officer
Tulsiram “Ram” Prathapam
Chief Scientist and Head of Compliance
Kenny Henry
Chief Information Officer
Randal Leslie
Vice President/General Manager Lab Management
Katie Truesdell
Human Resources Officer
Board of Managers Executive Committee
Bill Jackson
Principal Officer
